Applications Published 19 May 2001

Published: 9-Feb-2002

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).

  • Method to make snow for insect control and device for making same
    Eliasson, Bertil; Hallberg, Per-Ake 1096851*

  • Skin and tissue care and/or treatment agent
    Mandorlo Investment 1096918*

  • Systems and methods for local delivery of an agent
    CR Bard 1096919*

  • Scented oxygen
    Messer Griesheim 1096920*

  • Liposomal encapsulated nucleic acid-complexes
    Inex Pharmaceuticals 1096921*

  • Improved stable topical ascorbic acid compsns
    Shaklee Corp 1096922*

  • Blister containing a single transdermal therapeutic system and a single dose form of administration
    LTS Lohmann Therapie-Systeme 1096923*

  • Use of inhibitors of prenyltransferases for inhibiting fungal growth
    Mitotix 1096925*

  • Methods and compounds for treating depression
    NPS Pharmaceuticals 1096926*

  • Compsn for treatment of stress
    Massachusetts Institute of Technology 1096927*

  • New pharmaceutical preparation and method
    A+ Science Invest 1096928*

  • Therapeutic compsn based on flavonoids for use in the treatment of tumours with cytotoxic agents
    Laboratoires L Lafon 1096929*

  • Therapeutic compsn based on flavonoids for use in the treatment of tumours with cytotoxic agents
    Laboratoires L Lafon 1096930*

  • Use of (S)-(-)-amisulpride for the manufacture of a medicment for the treatment of schizophrenia
    Sanofi-Synthelabo 1096931*

  • Antihypertensive combination of valsartan and calcium channel blocker
    Novartis 1096932*

  • Use of an inhibitor of cytochrome P450 optionally combined with an antifungal agent for treating mycoses
    Investigations Therapeutiques essais cliniques services 1096933*

  • Oxazolidinones to treat eye infections
    Pharmacia & Upjohn 1096934*

  • Medicinal product and method for treatment and prevention of dyskinesia
    A Carlsson Research 1096935*

  • Treatment of dyskinesia
    The Victoria University of Manchester 1096936*

  • Sustained release ranolazine formulations
    CV Therapeutics 1096937*

  • Anti-irritant compsns containing a cyclic 2'-deoxy-nucleotide
    E-L Management 1096938*

  • Nocathiacin antibiotics
    Bristol-Myers Squibb 1096939*

  • Biocompatible and biodegradable compsns containing hyaluronic acid and the derivatives thereof for the treatment of ulcers in the digestive system
    Fidia Advanced Biopolymers 1096940*

  • Bone marrow cells as a source of neurons for brain and spinal cord repair
    University of South Florida 1096941*

  • Use of a medicine containing a quantity of tyrothricine for the treatment of viral infections
    Karl Engelhard Fabrik 1096942*

  • Method of preparation and pharmaceutical compsn of an Uncaria water soluble extract
    Pero, Ronald 1096943*

  • Extracts of Zanthoxylum bungeanum, pharmaceutical and cosmetic formulations containing them
    Indena 1096944*

  • Lysine binding fragments of angiostatin
    Bristol-Myers Squibb 1096945*

  • Delta cleavage products and methods based thereon
    Yale University 1096946*

  • Topical drug for the treatment of viral infections
    Karl Engelhard Fabrik 1096947*

  • Use of Interleukin-11 to treat gastrointestinal disorders
    Genetics Institute 1096948*

  • Treatment of celiac disease with interleukin-15 antagonists
    The Mathilda and Terence Kennedy Institute of Rheumatology 1096949*

  • Therapies using hemoproteins
    Duke University Medical Centre 1096950*

  • Use of bromelain proteases for inhibiting blood coagulation
    Ursapharm Arzneimittel 1096951*

  • Polysaccharide vaccine for staphylococcal infections
    The Brigham and Women's Hospital 1096952*

  • Use of inactivated immunosuppressive and/or angiogenic, immunogenic proteins, preparation method and pharmaceutical or vaccine uses
    Vacs International 1096953*

  • Adjuvant and vaccine compsns containing monophosphoryl lipid A
    American Cyanamid 1096954*

  • Cancer treatment method using antibodies to aminophospholipids
    Board of Regents, the University of Texas System 1096955*

  • Intracellular sensitisers for sonodynamic therapy
    Pharmacyclics 1096956*

  • Methods and reagents for intramuscular delivery of nucleic acids
    Johns Hopkins University School of Medicine 1096957*

  • Crystalline salts of dodecyl-2-(N, N-) dimethylamino)-propionate
    Nexmed Holdings 1097126*

  • Diacylhydrazine derivatives as integrin inhibitors
    Merck 1097127*

  • Imidamide derivatives
    Bayer 1097128*

  • N-benzocycloalkyl-amide derivatives and their use as medicaments
    Novartis 1097129*

  • Method for preparing hydroxymethylthiobutyric acid
    Aventis Animal Nutrition 1097130*

  • Method for separating hydroxymethylthiobutyric acid
    Aventis Animal Nutrition 1097131*

  • Functional vitamin D derivatives and a method for determining 25-hydroxy-vitamin D and 1-alpha,25-dihydroxy-vitamin D
    Immunodiagnostik Gesellschaft fuer Produktion und Vertrieb von Labordiagnostika 1097132*

  • Method for preparing vitamin A
    Aventis Animal Nutrition 1097133*

  • Arylpiperazine derivatives useful as uroselective alpha1-adrenaoceptor blockers
    Ranbaxy Laboratories 1097134*

  • Process for the preparation of an indole derivative
    SmithKline Beecham 1097135*

  • Process for the preparation of an indole derivative
    SmithKline Beecham 1097136*

  • N-substituted naphthalene carboxyamides a neurokinin-receptor antagonists
    AstraZeneca 1097137*

  • Pharmaceutical compsns containing 2-quinolones
    Laboratoire L Lafon 1097138*

  • Quinoline derivatives
    Active Biotech 1097139*

  • Biphenylsulphonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic, and drug containing them
    Aventis Pharma Dutschland 1097140*

  • azole derivatives with biphenyl-sulphonyl substitution, method of preparing them and their use as a drug or diagnostic agent
    Aventis Pharma Deutschland 1097141*

  • Phthalazine derivatives phosphodiesterase 4 inhibitors
    Zambon Group 1097142*

  • Method for preparing 4,6-disubstituted 2-isocyanatopyrimidines and to their use as intermediate products for active ingredient syntheses
    Aventis Pharma Deutschland 1097144*

  • Polyhydroxyalkylpyridine derivatives and their preparation and medicines containing them
    Aventis Pharma 1097145*

  • Method for producing 2-amino-4-chloro-1,3,5-triazines
    Aventis CropScience 1097146*

  • Novel angiogenesis inhibitors
    Merck 1097147*

  • Polymorph of ritonavir
    Abbott Laboratories 1097148*

  • Bicyclohexane derivatives
    Eli Lilly 1097149*

  • Imidazolyl
    derivatives 1097150*

  • Improved process for synthesising carbapenem intermediates
    Merck 1097151*

  • Synethesis of compounds useful in the manufacture of ketorolac
    Mallinckrodt 1097152*

  • Novel triazolo(4,5-D)pyrimidine compounds
    AstraZeneca 1097153*

  • Substituted benzimidazioles, production and use thereof as agents for combating parasitic protozoas
    Bayer 1097154*

  • Photochromic six-membered heterocyclic-fused naphthopyrans
    Transitions Optical 1097155*

  • Photochromic benzopyrano-fused naphthopyrans
    Transitions Optical 1097156*

  • Organometallic compsns
    ICI 1097157*

  • Ligands for metal and metal-catalysed processes
    Massachusetts Institute of Technology 1097158*

  • Phosphinous and phosphonic acid derivatives used as medicaments
    Aventis Pharma Deutschland 1097159*

  • Preparation and use of alpha-keto bisphosponates
    University of Southern California 1097160*

  • Oligonucleotides having site specific chiral phosphorothioate internucleside linkages
    Isis Pharmaceuticals 1097162*

  • Improved glycosylation method using sulphoxide donors
    Princeton University 1097163*

  • Process for coupling amino acids using bis-(trichloromethyl) carbonate
    Peptor 1097164*

  • Novel inhibitors of angiogenesis and tumour growth
    Gill, Parkash 1097165*

  • Potassium channel polypeptide and polynucleotide compsns
    Elan Pharmaceuticals 1097166*

  • Neurotrophic growth factor
    Janssen Pharmaceutica 1097167*

  • Compounds and methods for modulating cadherin-mediated functions
    Adherex Technologies 1097168*

  • Mouse growth hormone secreatgogue receptor
    Merck 1097169*

  • Growth hormone secretagogue related receptors and nucleic acids
    Merck 1097170*

  • Method for purifying haemoglobin
    Biopure Corp 1097171*

  • Anti hepatitis C virus antibody and uses thereof
    Connex Gesellschaft zur Optimierung von Forschung und Entwicklung 1097172*

  • Peptides of of IL-2 and derivatives thereof and their use as therapeutic agents
    Institut Pasteur 1097173*

  • Lupus anticoagulant antibody to F1 region of prothrombin.
    Gradipore 1097174*
    See more

    • You may also like

    Finance

    Shilpa Medicare opens flow chemistry manufacturing centre

    Read more
    The flow chemistry centre of excellence includes more than 100 R&D and manufacturing scientists

    Trending Articles

    1. Thermo Fisher Scientific highlights its new accelerator drug development solutions at CPHI Frankfurt 2025 The company has also announced a collaboration with OpenAI as well as a new digital toolbox, OSDPredict, which combines AI and machine learning models to predict formulation behaviour in small-molecule development
    2. Merck Life Science announces closure of Arklow facility Merck has said it will close the plant in Co Wicklow, Ireland, by the end of 2028, with the loss of 100 jobs
    3. Agarose Bead Technologies marks 25 years with $10m global expansion plan The Spanish agarose resin specialist will expand into the US and India, invest in scalable bioprocessing technologies and enhance sustainability across its European facilities to meet growing demand for advanced therapy purification
    4. Aseptic spray drying: Transforming biotherapeutics for a new era With interest in aseptic spray drying on the rise in the pharmaceutical industry, Dr Kevin Robinson spoke to GEA’s David Costes about how the company is combining process, engineering and technological expertise with market insights to provide a safe, reliable and high-performance technology for advanced biotherapeutic powder applications
    5. Sheffield University’s Energy Innovation Centre advances sustainable aviation Precision Anton Paar instruments support cutting-edge SAF research

    You may also like

    Finance

    Shilpa Medicare opens flow chemistry manufacturing centre

    The flow chemistry centre of excellence includes more than 100 R&D and manufacturing scientists
    Manufacturing

    Frontline innovation: dispatches from the show floor at CPHI Frankfurt (part III)

    The third instalment from the CPHI Frankfurt show floor explores practical approaches and fresh perspectives on scale-up, tech transfer, and manufacturing innovation across the pharmaceutical sector
    Research & Development

    Immunology CRO reports shift to autoimmunity projects

    RoukenBio reports a sharp rise in autoimmunity drug development projects and an almost 50% decrease in immuno-oncology (I-O) studies, showcasing the shift in drug development trends
    Research & Development

    Merck partners with Promega to advance 3D cell drug discovery technologies

    Partnership combines Merck’s chemistry and organoid expertise with Promega’s assay technologies
    Manufacturing

    OPTIMA machinery USA Corporation marks 40 years of growth and innovation in the US

    OPTIMA machinery USA Corporation, a subsidiary of the German-based OPTIMA Packaging Group, is celebrating 40 years of successful operations in the United States
    Manufacturing

    Streamlining bioconjugation for next-generation ADC development

    Abzena’s proprietary ThioBridge™ technology delivers precision, scalability, and enhanced stability for antibody-drug conjugates
    Regulatory

    TurboFil offers industry-leading glove testing systems

    Partnership with RAVONA delivers precision and compliance in aseptic environments
    Subscribe now